AAPG Competitors & Alternatives
Compare Ascentage Pharma Group International with similar stocks in the same industry
Biotechnology
AAPG
Main Stock$18.50
Tradestie Score
56
Market Cap
$3.68B
Revenue Growth
1.2%
Analyst Upside
+157.1%
Top Competitors
233 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ABCL
AbCellera Biologics Inc. Common Shares
|
$8.11
|
$1.78B | - | 59 | Compare |
|
DYN
Dyne Therapeutics, Inc. Common Stock
|
$23.07
|
$1.78B | - | 57 | Compare |
|
VRDN
Viridian Therapeutics, Inc. Common Stock
|
$19.40
|
$1.74B | - | 67 | Compare |
|
CLDX
Celldex Therapeutics, Inc
|
$38.37
|
$1.68B | - | 57 | Compare |
|
MNKD
Mannkind Corporation
|
$4.52
|
$1.65B | - | 66 | Compare |
|
MPLT
MPLT
|
$37.09
|
$1.63B | - | 53 | Compare |
|
EWTX
Edgewise Therapeutics, Inc. Common Stock
|
$39.56
|
$1.63B | - | 58 | Compare |
|
BHVN
Biohaven Ltd.
|
$15.96
|
$1.57B | - | 57 | Compare |
|
VCEL
Vericel Corporation
|
$46.98
|
$1.56B | 105.0 | 59 | Compare |
|
DNTH
Dianthus Therapeutics, Inc. Common Stock
|
$94.34
|
$1.55B | - | 57 | Compare |
More AAPG Analysis
Data updated: Jul 03, 2026 | Industry: Biotechnology (SIC 2834)
233 stocks in this industry